BrainsWay Ltd has a consensus price target of $21.33 based on the ratings of 4 analysts. The high is $30 issued by HC Wainwright & Co. on January 26, 2026. The low is $11 issued by Oppenheimer on May 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on January 26, 2026, December 8, 2025, and November 13, 2025, respectively. With an average price target of $24 between HC Wainwright & Co., there's an implied 88.38% upside for BrainsWay Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for BrainsWay (NASDAQ:BWAY) was reported by HC Wainwright & Co. on January 26, 2026. The analyst firm set a price target for $30.00 expecting BWAY to rise to within 12 months (a possible 135.48% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for BrainsWay (NASDAQ:BWAY) was provided by HC Wainwright & Co., and BrainsWay maintained their buy rating.
There is no last upgrade for BrainsWay
The last downgrade for BrainsWay Ltd happened on November 16, 2023 when Raymond James changed their price target from N/A to N/A for BrainsWay Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrainsWay, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrainsWay was filed on January 26, 2026 so you should expect the next rating to be made available sometime around January 26, 2027.
While ratings are subjective and will change, the latest BrainsWay (BWAY) rating was a maintained with a price target of $24.00 to $30.00. The current price BrainsWay (BWAY) is trading at is $12.74, which is out of the analyst’s predicted range.
